ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
Use this ICCC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ICCC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ICCC SEC filings page. Lician reads the product cache first so this HTML stays unique to ImmuCell Corporation even when a live quote feed is slow.
Latest cached year on this hub. Full ICCC income, balance, and cash tables.